ArticleJournal of epidemiology and global health2026
HIV/AIDS in Conflict-Affected Countries, 2024-2025.
Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConflict reverses development gains and can intensify HIV challenges by driving displacement, poverty, sexual violence, and the collapse of health systems. These conditions may disrupt HIV testing, treatment initiation, and continuity of care. Given recent alerts of an increase in armed conflicts to historic highs, we conducted an ecological analysis of the strength of the relationships between conflict severity and HIV outcomes in select conflict-affected countries.
methodsWe identified conflict-affected countries listed in all three data sources as of August 2025-the Armed Conflict Location and Event Data, Uppsala Conflict Data Program, and the World Bank. We extracted the most recent data from the Joint United Nations Programme on HIV/AIDS (UNAIDS) data on HIV incidence, prevalence, and the 95- 95-95 targets (95% of all people living with HIV have been diagnosed, 95% of those diagnosed are receiving antiretroviral therapy, 95% of those on antiretroviral therapy have achieved viral suppression). We used Pearson correlation to assess the strength of associations between conflict severity and HIV indicators.
findingsIn the 22 countries included in the analysis, HIV prevalence ranged from 0.1% in Syria and Iraq to 11.6% in Mozambique. None of the countries met all three 95-95-95 targets based on available UNAIDS data, although Cameroon achieved 95% awareness of HIV status. We did not identify strong associations between conflict severity and HIV prevalence, incidence, or progress toward the UNAIDS 95-95-95 cascade targets.
interpretationHIV indicators in conflict affected countries are within the range reported for other countries. We hypothesize that sustained external funding from the U.S. President's Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, may have helped minimize potential effects of conflict on UNAIDS 95-95-95 cascade targets in countries with high preexisting HIV burden. Strengthening the monitoring of HIV indicators can help resource allocation and preparedness of health systems in the post-conflict reconstruction period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.